Avanos Medical (AVNS) Other Non-Current Assets (2013 - 2026)

Avanos Medical has disclosed Other Non-Current Assets across 14 years of filings, most recently posting $32.9 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $32.9 million, up 29.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.9 million (up 29.53% YoY), and the FY2025 annual result was $31.5 million, up 35.78% from the prior year.
• Other Non-Current Assets came in at $32.9 million for Q1 2026 at Avanos Medical, up from $31.5 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $108.7 million in Q2 2023 to a low of $15.9 million in Q1 2022.
• The 5-year median for Other Non-Current Assets is $21.2 million (2023), against an average of $30.6 million.
• Across the five-year window, Other Non-Current Assets surged 558.79% in 2023 and tumbled 84.64% in 2024, its largest moves.
• Avanos Medical's Other Non-Current Assets stood at $17.6 million in 2022, then climbed by 9.66% to $19.3 million in 2023, then climbed by 20.21% to $23.2 million in 2024, then surged by 35.78% to $31.5 million in 2025, then advanced by 4.44% to $32.9 million in 2026.
• The last three Other Non-Current Assets figures came in at $32.9 million (Q1 2026), $31.5 million (Q4 2025), and $29.3 million (Q3 2025), per Business Quant data.